RHO CAPITAL PARTNERS INC
Follow13F filer, CIK 1020455, NEW YORK, NY
RHO CAPITAL PARTNERS INC reported $41,190,272 across 3 holdings for the quarter ended 2022-12-31, in a 13F-HR filed 2023-02-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-23-000636
- Period
- 2022-12-31
- Reported value
- $41.2M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 1
Holdings, Q4 2022
Share positions as resolved from 13F-HR 0001420506-23-000636, largest first. % of portfolio is the value over $41,190,272, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| CHARGEPOINT HLDGS INCCHARGEPOINT HLDGS INC | 4,053,257 | $38.6M | 93.78% | 0 | |||
| LIVEONE INCLIVEONE INC | 3,724,137 | $2.4M | 5.82% | 0 | |||
| SENSEONICS HLDGS INCSENSEONICS HLDGS INC | 159,601 | $164K | 0.4% | 0 |
Sold out in Q4 2022
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| Mersana Therapeutics IncMersana Therapeutics Inc | 0 | $0 | shares |
How Q4 2022 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001420506-23-000636 | base | 2023-02-14 | acceptance time not in the bulk data set |